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Chronic respiratory disease (CRD) is usually understood to include chronic 
bronchitis, emphysema, asthma, and a number of other chronic bronchopul- 
monary diseases. This paper will concentrate on the first two. The epidemi- 
ology of asthma differs in many ways from that of chronic bronchitis and 
emphysema, for example, in its age and sex incidence, relationships to social 
class, allergy, and time trends. But many of the clinical features are common 
to all three diseases with the result that diagnosis may be difficult. Further- 
more the extent to which asthma contributes to emphysema is as yet uncer- 
tain. While it would be desirable to consider the epidemiology of the compo- 
nents of CRD separately this is unfortunately not yet possible. A number of 
conferences and organizations (2,17,104) have suggested definitions and 
classifications of these diseases. The following definitions, essentially those 
of the American Thoracic Society, would probably be generally accepted. 
Chronic bronchitis is a clinical condition characterized by excessive 
mucous secretion in the bronchi. It is manifested by chronic or recurrent 
productive cough not attributable to other lung or heart disease. 
Emphysema refers to an anatomical alteration of the lung characterized by 
an abnormal enlargement of the air spaces distal to the terminal, nonrespira- 
tory bronchiole, usually accompanied by destructive changes in the alveolar 
walls. 
Asthma is a condition characterized by increased responsiveness of the 
trachea and bronchi to various stimuli. It is manifested by widespread nar- 
rowing of the airways which changes in severity either spontaneously or as a 
result of treatment. 
During the past 20 years epidemiologists have developed standardized 
methods for studying CRD (3,35,36,65). Precisely worded questions about 
respiratory symptoms and chest illnesses have been formulated, simple tests 
of ventilatory lung function, notably the forced expiratory volume (FEV) and 
forced vital capacity (FVC), have been widely applied, various objective 
methods, such as measurement of the volume and quality of the morning 
sputum during the first hour or half hour after rising, have been recommended 
(93). Bronchial reactivity has occasionally been measured. More sophisticated 
testing of lung function and chest radiography have been included in some 
surveys. The result is a considerable body of knowledge on chronic bronchitis 
but rather less on emphysema and asthma. 
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TABLE I 
NUMBERS OF DEATHS AND PERCENTAGE DISTRIBUTION FROM 
CHRONIC RESPIRATORY DISEASE: UNITED STATES, 1967 
United States 




Chronic Respiratory Disease 
Asthma (241”) 
Bronchitis-chronic & 
unqualified (501 & 502) 
Emphysema without mention 
of bronchitis (527.1) 
Pneumoconiosis (523, 524) 
Other chronic interstitial 
pneumonia (525) 
Bronchiectasis (526) 
Other (527.0 & 527.2) 
Cancer of trachea, bronchus, 
& lung (162 & 163) 














u International Statistical Code. 
SIZE OF THE PROBLEM IN THE UNITED STATES 
Thirty to forty thousand people die each year in the United States from 
chronic respiratory disease (Table I). This is about 2% of all deaths. It 
can be compared with 3% of all deaths from cancer of the bronchus and 
lung and 0.3% from respiratory tuberculosis. Each year there are 50- 
60,000 additional deaths in which chronic respiratory disease is men- 
tioned as contributing to death. The 30,000 deaths from chronic bronchitis, 
emphysema, and asthma now ranks them ninth among all causes of death. 
Over 15,000 middle aged Americans are disabled each year by these diseases. 
Social Security Administration records indicate that from 1959 to 1962 they 
were responsible for 10% of all disability awards. Approximately 10% of all 
disability of one week or more is attributed to CRD. Between July, 1964 
and June, 1965 roughly 2% of men and women aged 17 years and over who 
were interviewed in the National Health Survey reported chronic bronchitis 
and/or emphysema. But this must be a gross underestimate since surveys of 
several communities have indicated a prevalence of up to 40% depending on 
age, sex, and definition of disease. 
TIME TRENDS 
During the early decades of this century death rates from CRD in the U. S. 
declined rapidly. They remained low during the 1930’s and 1940’s. But since 
1949 there has been a steady rise in the death rates from emphysema (24). 
More recently there has also been a rise in death rates from chronic bronchitis 
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in men. The rise in the emphysema rates has been noted in all States and also 
in certain cities (22). It has affected both men and women and white and non- 
white. How much this trend is real and how much it reflects changes in diag- 
nostic fashions is debatable. But it would seem reasonable to conclude that at 
least some of it is real. 
In certain countries, though not in the United States, there was a marked 
increase in deaths due to asthma during the 1960’s (86, 87). In England and 
Wales the 5-34 age group was mainly affected with particular emphasis on 
those aged lo-14 years. Among them asthma mortality increased nearly eight 
times in seven years and in 1966 it comprised 7% of all deaths. Increases were 
also noted in Australia (39), New Zealand, Ireland, various western European 
countries and Japan. The evidence suggests that the increased mortality was 
due to excessive use of bronchodilator aerosols (40,54,87). The recent demon- 
stration that excess mortality depended both on nebulizer sales and licensing 
of a concentrated preparation of isoproterenol (88) provides additional sup- 
port for this view. 
PLACE DIFFERENCES 
The remarkable international differences in bronchitis mortality, which 
received so much attention 10 to 15 years ago are now realized to have been 
de largely to different diagnostic practices. A more valid assessment of these 
differences is obtained by combining bronchitis mortality with mortality from 
other diseases of the respiratory system, which excludes acute infections and 
upper respiratory conditions. When this is done a forty-fold difference in 
bronchitis between the United States and the United Kingdom is reduced to a 
more reasonable three- or four-fold difference in chronic respiratory disease 
mortality. 
Within the United States there are considerable differences in chronic re- 
spiratory disease mortality. High rates occur in Arizona, Wyoming, New 
Hampshire, Vermont, and Florida. Differences in age distribution in these 
states can explain some of the difference. But climate, air pollution, occupa- 
tional exposures, and migratory patterns may also contribute. 
In England and Wales a close association between density of population 
and bronchitis mortality has long been demonstrable. But in the United 
States differences in mortality from chronic respiratory disease between 
urban and rural areas are less striking (62). They have been found for men 
but not for women. 
FACTORS RELATED TO CRD 
Age and Sex 
In nearly all countries age-adjusted and age-specific mortality rates for CRD 
are higher in men than in women. In adult life mortality rates increase with 
age in both sexes. In many countries the rate of increase is greater in men than 
in women. In the U. S. for example the sex ratio of mortality for chronic 
bronchitis and emphysema increases from two to one at ages 35-44 to nine to 
one at ages 65-74, while at all ages combined it is five to one. Most morbidity 
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surveys have shown a higher prevalence of cough, sputum and wheeze 
among men compared with women. Much of this excess is probably due to 
differences in smoking habits (74). Chest illnesses during the past three years 
appear to be equally common in both sexes, and breathlessness is commoner 
in women (75). 
The prevalence of breathlessness increases consistently with age but that of 
the other symptoms is less consistently related to age. Cough and sputum 
prevalence increases in some areas but not in others. It may be determined to 
some extent by air pollution as well as by smoking. Wheezing in the chest and 
chest illnesses during the past three years have been found to be inconsis- 
tently related to age. 
Many studies have shown that ventilator-y lung function declines with age 
(75,89,92). Thus fr om about the age of 25 there is a fairly uniform, linear 
decline in the forced expiratory volume (FEV) which appears to be rather sim- 
ilar in different countries. The regression of the one second FEV on age and 
height based on a number of surveys in different countries given by Cotes 
et al. (21) is 
FEV,., = 3.62 height (meters) - 0.031 age (years) - 1.41 (SD. 0.5) 1BTPS 
The FEV in women is roughly 75% of that found in men of the same age. Most 
of the difference can be explained by differences in height, but some residual 
differences may be due to smoking or occupational exposures. 
Socio-economic Circumstances 
In England and Wales for many years there has been a striking gradient of 
increasing mortality from bronchitis with decreasing social class leading to a 
six-fold difference between the highest (most privileged) and the lowest 
classes (90). More recently in Britain a similar pronounced morbidity gradient 
with social class has been demonstrated (19,69). The cause of this gradient is 
not clear. Poor housing, domestic overcrowding with greater opportunity for 
cross infection, infections early in life, occupational exposures, too early re- 
turn to work (especially heavy work) after respiratory infections, residence of 
the poor in more polluted parts of cities, differences in the quality of medical 
care and social drift whereby those with CRD tend to descend in the social 
scale are some of the suggestions which have been offered. In the U. S. the 
association between socio-economic level and CRD appears to be much less 
striking than in Britain. There is only a roughly two-fold difference in mortal- 
ity between professional and unskilled workers. An inverse relationship 
between income level and respiratory disease has sometimes been found. 
Several recent surveys have also suggested that the prevalence of respiratory 
symptoms and chronic bronchitis may be higher and the level of ventilator-y 
lung function may be lower in the less well-educated. 
Heredity 
The prevalence of chronic bronchitis is higher in the first degree relatives of 
bronchitic patients than in the relatives of controls (50,73,90). Estimates vary 
with the age and sex of the group under consideration but prevalence has 
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usually been about twice as high in the relatives of persons with bronchitis. In 
Tecumseh in addition to familial aggregation of bronchitis, levels of FEV 
have also been shown to be correlated in index persons and their first degree 
relatives. Some of this family resemblance is due to environmental rather than 
to genetic factors. It has been shown for example that there is familial aggrega- 
tion of smoking habits (50). 
More recently support for a hereditary factor has come from twin studies. 
Cederlof and his colleagues (13-15) have shown that concordance rates for 
cough, persistent cough, and bronchitis among nonsmokers are significantly 
higher among monozygotic than among dizygotic twins indicating a genetic 
influence. By comparing the prevalence of these conditions in monozygotic 
twin pairs, which differ in respect to such factors as smoking or urban/rural 
residence, with the appropriate values for the general population, an estimate 
of the relative importance of heredity and environment can be made. Such 
analyses have indicated that smoking is a more important cause of cough and 
bronchitis than hereditary predisposition, but that this may be important in 
some persons. 
Deficiency of the serum protein alpha-1-antitrypsin may result in the devel- 
opment of emphysema at a relatively early age (29,57). The deficiency is 
found in less than 2% of all cases of severe emphysema. It seems unlikely 
therefore to be a very important factor in most cases. But it has been suggested 
that 7.5% of Americans or more may be heterozygous carriers of the defi- 
ciency gene. If heterozygosity is associated with an increased susceptibility to 
emphysema such a high frequency could be very significant. There is at 
present uncertainty on the point. Some studies have suggested an increased 
incidence of CRD among heterozygotes (60); others (80) have failed to sup- 
port the suggestion. Clearly further work is needed. The importance of de- 
tecting those who are hereditarily predisposed to CRD is that particular 
attention can be given to them to avoid environmental determinants. 
Smoking 
Many surveys in many countries have shown that smoking is an important 
factor in CRD. These have been reviewed in considerable detail in the 
Health Consequences of Smoking, A Report to the Surgeon General: 1971 
(92). Only a brief summary of the findings will be presented here. 
Studies in which respiratory symptoms have been recorded in a standard- 
ized manner have shown that the prevalence of such symptoms is higher in 
cigarette smokers than in non-smokers both in men and in women. Smoking is 
particularly closely related to the frequency of cough and sputum, which 
increase progressively with increasing tobacco consumption. An effect of 
smoking on these symptoms has been noted at young ages (77,82), even in 
school children. In fact the prevalence of cough and sputum among teenagers 
who smoke five or more cigarettes a day may be little less than that of adult 
smokers (82). Wheezing in the chest usually shows a similar, though less 
marked, trend with cigarette consumption. The prevalence of chest illnesses 
and of breathlessness, while usually higher in smokers than in nonsmokers 
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have not been found to increase consistently with tobacco consumption. In 
ex-smokers the prevalence of these symptoms has usually been found to be 
closer to that of nonsmokers than of smokers. This is often particularly striking 
for cough and sputum. A lower prevalence of symptoms has also usually been 
found in pipe or cigar smokers. 
Many studies have shown that smoking is associated with reduced lung 
function (1,92). In epidemiological surveys ventilatory lung function has most 
often been assessed, usually be means of the FEV, FVC, or peak expiratory 
flow. Characteristically the FEV is lower in cigarette smokers than in non- or 
ex-smokers, but there has often been only a small difference’in the mean val- 
ues between the light and heavy smokers. Usually there is little difference in 
the mean FVC between smokers and nonsmokers. Consequently the 
FEV/FVC% is especially reduced in smokers. The ventilatory capacity of ex- 
smokers and of pipe or cigar smokers is usually only slightly lower than that of 
nonsmokers. Lung volumes (7), airways resistance and transfer factor have 
been included in a few epidemiological surveys. They have shown that these 
other aspects of lung function are also lower in smokers than in nonsmokers. 
The lower lung function values found in smokers are mainly associated with 
the presence of respiratory symptoms; but even in those without symptoms 
smoking has sometimes been shown to be associated with lower ventilatory 
function (77,100). 
Relatively few studies of trends in lung function over time according to 
smoking habits have been made (34,48,99). The findings from a nine year 
follow-up of a survey of a representative sample of men living in Staveley, 
Derbyshire, an English industrial town, are shown in Table II. The mean val- 
ues at the initial survey in 1957 support the statements, which have already 
been made. The decline in FEV over the nine years is related to the smoking 
habits which were recorded at the first survey. There was a higher decline in 
smokers than in nonsmokers and in heavier compared with lighter smokers. 
The decline was intermediate in ex-smokers and in smokers of pipes or cigars. 
In this study there was also a somewhat higher attack and a lower remission 
rate of respiratory symptoms among smokers compared with non-smokers. 
A wealth of information on smoking and mortality is available from the pro- 
spective studies which have been carried out on smoking and lung cancer (92). 
These show that death rates from bronchitis and emphysema rise with 
increasing cigarette consumption. Among British doctors (23) the mortality 
ratios for chronic bronchitis among those smoking 25 cigarettes a day and over 
were over 20 times as high as that of nonsmokers. Among U. S. veterans (56) 
ratios for chronic bronchitis were eight times and for emphysema 25 times as 
high in those who smoked 40 cigarettes or more daily as in nonsmokers. Rela- 
tively little information on smoking and CRD mortality is available for 
women. Hammond (47) found mortality ratios for emphysema in lighter and 
heavier smokers of nearly five and over seven times that for non-smokers 
respectively. But the number of deaths from emphysema among women was 
small. There is general agreement in all these studies that the mortality ratios 
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A lower mortality from CRD in those who gave up smoking has been noted 
in several of the prospective studies. In U. S. veterans the age-specific mortal- 
ity ratios of ex-smokers were lower than those of continuing smokers of similar 
amounts. In British doctors a reduction in bronchitis mortality was observed 
only after a delay of some five years. In recent years British doctors have 
shown a more favorable trend in bronchitis mortality than other men aged 
35-64 in the U. K. Between 1953-1957 and 1962-1965 their rates fell by 22% 
compared with a fall of only 4% in all men of this age. 
The benefit of stopping smoking has been noted for many years by clini- 
cians (55). Systematic observations have been rather limited (70,105). A reduc- 
tion in cough and sputum has usually been the most striking change. But a 
reduction in the number of exacerbations and of time lost from work have also 
been reported. In younger persons lung function may return to normal. The 
prevalence of persistent sputum has been shown to be somewhat lower in 
those who smoke filtered than nonfiltered cigarettes. Furthermore a recent 
controlled trial has supported the conlusion that switching to an effectively fil- 
tered brand of cigarettes would be beneficial (38). There is also evidence to 
support the view that respiratory symptom prevalence is higher in those who 
inhale moderately or deeply than in those who do not inhale or who inhale 
only slightly. 
Randomized trials of intensive antismoking advice have been started in 
Britain, but no results have yet been published. Similar trials are needed in 
this country to appraise the efficacy and value of these efforts. 
Air Pollution 
Evidence from a wide variety of epidemiological investigations (Table III) 
suggests that air pollution is a significant factor in CRD. There is no doubt 
about the effect of exceptional episodes of pollution such as those in the 
Meuse Valley in 1930 (32), Donora in 1948 (83), London in 1952 (67) and other 
years and New York City in 1953, 1963 (44), and 1966, on mortality and mor- 
bidity in general and from respiratory disease in particular. The effect does 
however seem to have been less in New York than in London. Much of the 
increase which occurred seems to have been in those who already had chronic 
disease of the heart or lungs (18,67). But involvement of young persons, even 
of infants, and of domestic and other animals, and the development of 
symptoms as pollution increased suggest that fog can initiate as well as ex- 
acerbate disease. 
There has been more doubt about the effect of lower, more sustained levels 
of pollution on respiratory disease. In London daily concentrations of smoke 
and SO, were fairly highly correlated with mortality and morbidity from all 
causes and from certain respiratory diseases from 1958 to about 1962. But 
since then there has been much less evidence of any such correlation. This is 
no doubt due to the remarkable decline in the concentrations of smoke and 
SO, which have occurred during the past 12 years in London (81). Even in es- 
pecially susceptible subjects, such as patients with bronchitis or emphysema, 
it is no longer possible as it used to be to correlate respiratory well being with 
daily pollutant levels (95-97). On the other hand in a study of men aged 30-59 
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TABLE III 
MAIN TYPES OF EPIDEMIOLOGICAL INVESTIGATIONS 
INTO THE EFFECTS ON HEALTH OF AIR POLLUTION 
1. Acute Episodes 
2. Follow-up of Donora, Pennsylvania 
3. Day to Day Variation in Mortality, Morbidity, and Lung Function 
(i) General Community 
(ii) Patients with Chronic Respiratory Disease 
4. Longitudinal Observations at Less Frequent Intervals 
5. Geographical Comparisons 
(i) International 
(ii) Within Countries by Region 
(iii) Urban/Rural Differences 
(iv) Uniform Occupational Groups 
(v) Comparisons Between Towns 
(vi) Comparisons Within Towns 
6. Studies of Children 
7. Miscellaneous Studies 
(i) Migrants 
(ii) Twins 
(iii) Athletic Performance 
in north London, Fletcher was able to show that the incidence of a num- 
ber of respiratory illnesses was related to both smoke and SO, concentra- 
tion (4). A decline in the volume of morning sputum was also noted; but this 
could have been due to a concurrent reduction in the tar content of cigarettes. 
In this country McCarroll and his colleagues (63) followed a segment of the 
population of Manhattan Island for two years. Complaints of cough and of eye 
irritation were found to be related to SO, concentrations. Among bronchitis 
patients in Chicago the severity of symptoms has been shown to depend to 
some extent on pollution levels but there is some doubt about the extent to 
which this can be attributed to SO2 concentration (10,12). 
In a study of Canadian veterans Bates (5,6) and his colleagues found 
that patients with chronic bronchitis in Winnipeg were less severely affected 
and had better lung function, which declined less during the four years of 
observation, than patients in Toronto, Montreal, and Halifax. Winnipeg is 
much the least polluted of the four cities in terms of dust fall and SO, 
levels. 
Many geographical comparisons relating pollution to indices of respiratory 
diseasehave beencarriedout(43,51,52,59,69,71,72,76,78,79,98). Someofthein- 
temational differences in CRD mortality can be explained by differences in 
death certification. But even when these are allowed for and differences in 
smoking habits are also considered death rates from CRD are appreciably 
higher in Britain than in the United States or Scandinavia (16~1). Carefully 
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standardized studies of morbidity have supported conclusions based on death 
rates (52,71,72,79). Thus while the prevalence of cough and sputum in Berlin, 
N. H. was similar to that found in rural and urban Britain, bronchitis with 
recurrent illnesses and breathlessness was commoner in Britain, especially 
among older people in larger towns. In a carefully standardized comparison of 
CRD in unpolluted Chilliwack, B. C. and moderately polluted Berlin, N. H., 
Ferris and Anderson (30) noted that ventilatory capacity was consistently 
above expectation in both men and women for all smoking categories in 
Chilliwack. Mortality and morbidity from respiratory disease has often been 
related to levels of air pollution in Britain. Earlier studies often had to use 
indirect measures of pollution, such as fuel consumption per acre. More 
recent studies have more often used measurements of smoke or SO, collected 
through the National Air Sampling Network. Whatever the index of pollution 
used, these studies have nearly all shown a fairly close relationship between 
level of pollution and bronchitis mortality and morbidity. To get round the 
problem of the association of pollution levels with social class the uniform oc- 
cupational group has sometimes been used. Fairbaim and Reid studied 
postmen (mailmen) who work in different parts of the country, which vary 
widely in levels of pollution. Premature retirement and death from bronchitis 
was highest among postmen in more polluted areas. 
In this country extensive studies of air pollution have been made in Nash- 
ville, Tennessee (106-108) and Buffalo, New York (101-103). In Nashville 
respiratory disease mortality was related to sulphation levels and various indi- 
ces of morbidity, such as frequency of asthmatic attacks, to sulphation and 
soiling. In Buffalo pollution was monitored extensively from 1961 to 1963. 
Levels of pollution were related to mortality from 1959 to 1961. Mortality from 
all causes in men aged 50 years and over and respiratory disease mortality in 
men aged 50-59 was correlated with suspended particulate concentrations 
(Table IV). There was also a correlation between sulphation levels and respi- 
ratory disease mortality in men aged 50 and over. In a subsequent study of 
women the prevalence of cough and sputum was shown to be related to sus- 
pended particulate concentrations. 
Some of the most significant effects of pollution on the respiratory system 
have been demonstrated in children. A higher prevalence of sinus infection, 
chronic otitis media (94), respiratory symptoms and chest illnesses, and lower 
ventilatory lung function (61) as assessed by FEV, FVC, and peak flow rates, 
have been associated with higher levels of pollution. One of the most interest- 
ing studies was that conducted by Douglas and Waller (25). Illness experience 
was related to levels of lifetime pollution experienced by a national sample of 
children born in 1946 and studied intensively until they left school in 1961. 
The findings were clear and consistent. Lower respiratory illnesses were 
related to air pollution; upper respiratory illnesses were not. The lowest 
illness rates were found in those who had experienced the lowest levels of 
smoke and SOZ, namely an average annual concentration of 70 and 90 pglm3. 
Higher illness rates were found in all higher pollution categories. The higher 
rates did not appear to be explainable on the basis of social class. 
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TABLE IV 
MEAN ANNUAL DEATH RATES PER 100,000 POPULATION FROM ASTHMA, 
BRONCHITIS OR EMPHYSEMA ANYWHERE ON THE DEATH CERTIFICATE 






Mean annual particulate 
concentration (pg/m”) 
<a0 BO- loo- 135-t 
3005-5007 126 271 392 
5 175-6004 136 154 172 199 
6013-6614 74 110 128 
6618-7347 70 80 177 
7431-11,792 79 109 Ob 
a White Males Aged 50 to 69 Years in Buffalo, New York, 1959-1961. Winkelstein et al., (1967). 
* Rate based on less than 5 deaths. 
Evidence which permits one to recommend standards for particulate and 
SOP concentrations is scanty. This study suggests that the maximal permis- 
sible annual concentrations of smoke or of SO, should both be under 100 
pg/m3. Support for this statement can be drawn from the nationwide Enquiry 
into the Incidence of Incapacity from Bronchitis and from the random sample 
of Britain studied by Lambert and Reid. In Buffalo the findings on mortal- 
ity suggested that an annual concentration of suspended particulates of less 
than 80 pg/m3 would be desirable. 
OCCUPATIONAL EXPOSURES 
During the 19th century in Britain authorities on respiratory disease had no 
doubt about the importance of occupational exposures as a cause of bronchitis. 
Thackrah and Greenhow (45) stressed the importance of dusts, particularly 
textile dusts, while in this century Collis (20) considered that bronchitis 
was chief of the dust diseases. But both Collis and Haldane pointed out 
that dusts varied in their effect according to their nature (42). In the mortal- 
ity statistics given by Co&., cotton strippers stood out with a nearly six-fold 
higher mortality rate for bronchitis than all men whereas none of the other oc- 
cupations he cited even reached a two fold excess. Haldane (46) reviewing 
the same material noted high rates among tin and copper miners and sand- 
stone workers as well as cotton strippers and grinders. Coal miners in En- 
gland and Wales have had consistently higher death rates from bronchitis than 
other men since 1900. But the excess has not been large, approximately 40% 
in most censuses. Furthermore the rates in the different coal fields has var- 
ied from less than the national average for all men of working age to approx- 
imately twice the average. 
In the United States occupational mortality statistics are available only for 
1950 (27). The high standardized mortality ratios (SMR) for mine operatives 
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and labourers and metal moulders are striking. The much higher ratios for 
coal miners in the U. S. (nine times the average for all men aged 20-64) com- 
pared with coal miners in England and Wales (1.4 times the average) is largely 
due to the inclusion of pneumoconiosis in the American statistics. If deaths 
from this cause are excluded the excess chronic respiratory disease ratios 
become much more similar in the two countries. The interpretation of mortal- 
ity statistics is difficult. Apart from questions about the accuracy of diagnoses, 
discrepancies between the census and death populations can lead to serious 
biases which make conclusions about the effect of probable levels of dust- 
iness on mortality exceedingly hazardous. The higher mortalities from bron- 
chitis among the wives of men with higher bronchitis SMR also suggests that 
some of the excess may be due to social rather than to occupational factors. 
In Britain morbidity statistics (68) available since 1948 have indicated that 
miners and foundry workers have higher rates of sickness absence from 
bronchitis than other men. How much this can be explained on the basis of 
the heaviness of the job is debatable. A survey of a random sample of all 
workers carried out in 1961/1962 confirmed the high rates for attacks of 
bronchitis in miners. It also showed above average incidence of bronchitis in 
furnace, forge, foundry men, gas, coke and chemical workers, and various 
other groups; but the excess in these occupations was not striking. 
Field surveys in which representative samples of the community, some of 
whom work or have worked in the occupation under investigation and others 
have not, have been carried out in various countries during the past 20 years 
(26,28,48,58,84,85). A summary of the findings in those which have used com- 
parablemethods is shown inTable V (42). The results are fairly consistent. In al- 
most all surveys, there was a higher prevalence of bronchitis and a lower 
mean ventilatory capacity among the men who were exposed to dust. The dif- 
ferences between dust-exposed and nondust-exposed groups varies in the dif- 
ferent surveys from 1: 1 to 6 : 1, but is most often around 2 : 1. With few excep- 
tions the differences in mean ventilatory capacity between the two groups 
support the view that those exposed to dust were more disabled. These dif- 
ferences cannot be explained on the basis of differences in smoking habits 
since they have been shown to persist after standardization for smoking. Their 
relation to dust exposure is not clear. Some studies have suggested that as life- 
time dust dosage, assessed either by the number of years spent working un- 
derground or at the coal face, increases, the prevalence of CRD increases and 
the level of ventilatory capacity declines (53,58,91). But other studies have 
indicated that at least in some areas any such trends may be inconsistent and 
that often they cannot be demonstrated at all (49). 
Another reason for concluding that lifetime dust exposure cannot be the 
whole explanation of the differences in CRD between dust-exposed and 
nondust-exposed persons is that in coal miners there is no close relationship 
between category of simple pneumoconiosis and either the prevalence of 
bronchitis or level of ventilatory capacity (42). On the other hand, a close 
relationship between X-ray category of simple pneumoconiosis and the total 














































































































































































































































































































































































































































































































































































































































































































































































































CHRONIC PULMONARY DISEASE PREVENTION FORUM 27 
Exposure to certain vegetable dusts is perhaps more liable to cause CRD 
than exposure to coal dust. No doubt some of the high mortality rates noted in 
the past among flax hecklers and cottonstrippers was due to the specific 
disease byssinosis, but more recent work has shown fairly convincingly that 
such workers also experience an increased prevalence of bronchitis as well as 
of byssinosis (26). Exposure to cotton, hemp, and flax dust has been shown to 
be associated with a decline in ventilatory capacity during the working shift 
(8,9,11,41,64). The decline is greatest on Mondays and becomes progressively 
less during the week. It is also usually greater in persons with byssinosis, but 
it may also occur in those without symptoms, The extent to which an acute 
response to the dust leads to permanent disability is at present uncertain. In 
contrast to this well marked acute effect on lung function of vegetable dusts 
exposures, coal dust exposure does not as a rule lead to any comparable 
decline. From the preventive standpoint it would seem reasonable to con- 
clude that while some occupational dust exposures may be more harmful 
than others no exposure is likely to be beneficial. Adequate control of dust 
at work is clearly desirable. 
INFECTION 
Differences between persons with chronic bronchitis and other people in 
the frequency of certain respiratory infections have sometimes been noted, 
Bronchitic subjects report a higher frequency of pneumonia, pleurisy and 
acute bronchitis in the past; a higher prevalence of stuffy nose and sinus infec- 
tion at the time of interview and a higher frequency of head colds, particularly 
of headcolds which “go down on the chest.” Some of these conditions appear 
to date back to childhood and it may well be true, as Reid has maintained, that 
the seeds of CRD are sown early in life. 
The degree to which the characteristic exacerbations of established CRD 
are due to infective agents is not yet certain. Fisher and her colleagues (33) in 
Edinburgh, Scotland showed that while there was a significant increase in 
bacterial (particularly pneumococci and H-influenzae), viral and mycoplasmal 
pathogens during exacerbations compared with quiescent periods, infective 
agents could be isolated in less than half the exacerbations. It seemed to them 
therefore that viral and mycoplasmal infections could not play a large part in 
exacerbations of bronchitis. Rather surprisingly infection does not appear to 
have as large an influence on the natural history of CRD as was generally sup- 
posed ten years ago. In the longitudinal study of chronic bronchitis conducted 
by Fletcher (33) in London from 1962 to 1966 neither exacerbations, nor vol- 
ume or purulence of sputum appeared to influence the rate of decline of the 
FEV. 
Support for this conclusion comes from controlled prophylactic and thera- 
peutic clinical trials of antibiotics in chronic bronchitis (89). Most of these 
have been carried out on advanced cases. But a few trials (37,66) have been 
specifically directed at early cases. Such a trial was that carried out in Britain 
by the Medical Research Council. The trial moreover lasted for five years and 
included patients from a wide area of the country. The design included an as- 
sessment of both prophylactic and therapeutic possibilities. While chemo- 
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therapy reduced the time lost from work by about a third and appeared to 
reduce the number of patients who had many exacerbations, it did not influ- 
ence either the volume or the purulence of the sputum nor did it affect the rate 
of decline in the FEV. 
LESSONS FROM EPIDEMIOLOGY FOR PREVENTION 
Epidemiological studies have shown clearly the overwhelming importance 
of smoking, particularly cigarette smoking, in the causation of CRD. There is a 
consistency about the findings in respect to smoking which is not present for 
the other major environmental factors. Apart from the direct effect it may have 
on the respiratory tract, interaction, which has sometimes been noted 
between smoking and air pollution or smoking and occupational dust ex- 
posure, suggests that smoking may act indirectly to modify the effect pro- 
duced by these other determinants. Clearly the major emphasis in any pro- 
gram of prevention of CRD must be on smoking. Don’t take it up, give it up, 
switch to a pipe, to cigars, or to more adequately filtered cigarettes, don’t 
inhale-these are the obvious recommendations in order of preference. 
At the same time when so much is involved both economically and from the 
standpoint of personal pleasure it is important to make every effort to measure 
what can be accomplished by persuasion or exhortation. The only satisfactory 
way of doing this is by randomized controlled trials. A start has been made 
along these lines; but much more remains to be done. 
Reduction in air pollution is obviously desirable on many grounds, not 
merely because of its effects on health. The remarkable reduction in air pollu- 
tion, particularly of smoke pollution, which has been brought about in Britain 
by the implementation of the Clean Air Act shows what can be accomplished 
by legislative action. Strict enforcement of National Air Quality Standards 
proposed for the United States should go far towards eliminating any effect of 
air pollutants. Monitoring the effect of reduction in pollution on CRD is 
highly desirable. Here because of the general implementation of the law con- 
trolled trials seem to be impossible. Instead we shall have to be content with 
observation of mortality and morbidity before, during, and after pollution 
reduction, or with small scale observations based on repeated observations in 
communities, which have reduced pollution such as that carried out by Ferris 
and his colleagues (31). The Environmental Protection Agency has made a good 
start with its Community Health and Environmental Surveillance System 
(CHESS). The observations being made should permit a more accurate as- 
sessment of the effects of specific pollutants and of critical levels than has 
previously been possible. Occupational exposures will no doubt be much 
more stringently controled in the future as a result of the Occupational Safety 
and Health and Mining Health and Saftey Acts. The legislation that miners 
must be offered examinations by chest X-ray and lung function tests should 
provide the needed evidence on the efficacy and adequacy of dust standards 
and at the same time identify any man who may be unduly sensitive to dust. It 
is not hard to foresee the extension of these requirements to other potentially 
hazardous industries. 
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Prompt and adequate treatment of acute respiratory diseases is clearly in- 
dicated from the reduction in lost working time which has been shown to 
result. That such therapy has not appeared to influence the rate of decline in 
lung function and so presumably has no very large effect on the natural history 
of the disease is disappointing. It does however emphasize that prevention, 
rather than early detection and treatment, is the only effective appoach to 
CRD. 
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